ArticleBreast cancer research : BCR2020

Plasma thymidine kinase 1 activity and outcome of ER+ HER2- metastatic breast cancer patients treated with palbociclib and endocrine therapy.

Luc Cabel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.